Elevated intact parathyroid hormone is associated with reduced biochemical markers of bone formation and resorption measured in blood in infant piglets receiving oral dexamethasone for 15 days

Biology of the Neonate

Volumn 80, Issue 4, 2001, Pages 295-299

  Guo, Chun Yuan ^a   Weiler, Hope ^b   Atkinson, Stephanie A ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Bone turnover; Corticosteroids; Parathyroid hormone; Piglets

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DEXAMETHASONE; OSTEOCALCIN; PARATHYROID HORMONE; PLACEBO; WATER;

ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE METABOLISM; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFECT; HORMONE DETERMINATION; MALE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SWINE;

ANIMALS; ANIMALS, NEWBORN; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; CALCIUM; DEXAMETHASONE; GLUCOCORTICOIDS; OSTEOCALCIN; PARATHYROID HORMONE; PLACEBOS; SWINE;

EID: 0034781664     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047159     Document Type: Article

References (35)

1. Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis
2. Effect of glucocorticoids on function of the parathyroid glands in man
3. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton
4. Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome
5. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects
6. Corticosteroid-induced bone loss in men
7. Urinary excretion of pyridinum cross-links of collagen in infancy
8. Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects
9. Urinary excretion of hydroxy-pyridinum cross-links of collagen reflects skeletal growth velocity in normal children
10. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency
11. Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants
12. Dexamethasone treatment impairs calcium regulation and reduces bone mineralization in infant pigs
13. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I
14. Glucocorticoid effects on bone
15. Comparison of urinary bone resorption markers in women of 40-70 years: Day-to-day and long-term variation in individual subjects
16. Response of biochemical markers of bone turnover to hormone replacement therapy: Implication of biological variability
17. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen
18. Intra-individual variation and response to anti-resorptive therapy assessed by bone resorption measurements with the serum CTx one step ELISA
19. Serum CTx: A new marker of bone resorption which shows treatment effect more often than other markers because of low CV and large changes with bisphosphonate therapy
20. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trial
21. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation
22. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia
23. Catabolic effect of dexamethasone in the preterm baby
24. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone
25. Calcium-regulating hormones, bone mineral content, breaking load and trabecular remodeling are altered in growing pigs fed calcium-deficient diets
26. Mineral bioavailability and bone mineral contents in pigs given calcium carbonate postprandially
27. Tamoxifen attenuates the effects of exogenous glucocorticoid on bone formation and growth in piglets
28. Improvement in the accuracy of dual energy x-ray absorptiometry for whole body and regional analysis of body composition: Validation using piglets and methodological considerations in infants
29. Sub-clinical vitamin D deficiency in neonates: Definition and response to vitamin D supplements
30. Effects of early postnatal dexamethasone therapy on calcium homeostasis and bone growth in preterm infants with respiratory distress syndrome
31. Management of corticosteroid-induced osteoporosis
32. Improved prediction of bone mineral content and density
33. Whole body bone mineral content in healthy children and adolescents
34. Total body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis